83 FR 26992 - Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting
DEPARTMENT OF DEFENSE
Office of the Secretary Federal Register Volume 83, Issue 112 (June 11, 2018)
Office of the Secretary
Federal Register Volume 83, Issue 112 (June 11, 2018)
| Page Range | 26992-26993 | |
| FR Document | 2018-12445 |
[Federal Register Volume 83, Number 112 (Monday, June 11, 2018)] [Notices] [Pages 26992-26993] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-12445] ----------------------------------------------------------------------- DEPARTMENT OF DEFENSE Office of the Secretary Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting AGENCY: Under Secretary of Defense for Personnel and Readiness, Department of Defense. ACTION: Notice of Federal Advisory Committee meeting. ----------------------------------------------------------------------- SUMMARY: The Department of Defense (DoD) is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel will take place. DATES: Open to the Public Thursday, July 12, 2018, from 9:00 a.m. to 12:00 p.m. ADDRESSES: The address of the open meeting is the Naval Heritage Center Theater, 701 Pennsylvania Avenue NW, Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Col Paul J. Hoerner, U.S. Air Force, 703-681-2890 (Voice), None (Facsimile), dha.ncr.health-it.mbx.baprequests@mail.mil (Email). Mailing address is 7700 Arlington Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: http://www.health.mil/About-MHS/Other-MHS-Organizations/Beneficiary-Advisory-Panel. The most up-to-date changes to the meeting agenda can be found on the website. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the Federal Advisory Committee Act (FACA) of 1972 (5 U.S.C., Appendix, as amended), the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended), and 41 CFR 102-3.140 and 102-3.150. Purpose of Meeting: The Panel will review and comment on recommendations made to the Director of the Defense Health Agency, by the Pharmacy and Therapeutics Committee, regarding the Uniform Formulary. Purpose of the Meeting: The Department of Defense is publishing this notice to announce a Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel) will take place. Agenda 1. Sign-In 2. Welcome and Opening Remarks 3. Scheduled Therapeutic Class Reviews (Comments will follow each agenda item) a. Gastrointestinal-2 Miscellaneous Agents--Opioid-Induced Constipation Subclass b. Growth Stimulating Agents c. Pancreatic Enzyme Replacement Therapy Agents 4. Newly Approved Drugs Review 5. Pertinent Utilization Management Issues 6. Panel Discussions and Vote Meeting Accessibility: Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 Code of Federal Regulations (CFR) 102-3.140 through [[Page 26993]] 102-3.165, and the availability of space, this meeting is open to the public. Seating is limited and will be provided only to the first 220 people signing-in. All persons must sign-in legibly. Written Statements: Written Statements: Pursuant to 41 CFR 102- 3.140, the public or interested organizations may submit written statements to the membership of the Panel about its mission and/or the agenda to be addressed in this public meeting. Written statements should be submitted to the Panel's Designated Federal Officer (DFO).The DFO's contact information can be obtained previously in this announcement. Written comments or statements must be received by the committee DFO at least five (5) business days prior to the meeting so that they may be made available to the Panel for its consideration prior to the meeting. The DFO will review all submitted written statements and provide copies to all the committee members. Dated: June 6, 2018. Shelly E. Finke, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2018-12445 Filed 6-8-18; 8:45 am] BILLING CODE 5001-06-P
![26992 Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices
Effective Teams, Class of 2022 Profile, stated agenda of the open meeting or in SUMMARY: The Department of Defense
SHARP (Sexual Harassment Assault regard to the committee’s mission in (DoD) is publishing this notice to
Response and Prevention) Program, general. Written comments or announce that the following Federal
Intellectual Capital and Outreach, statements should be submitted to Mrs. Advisory Committee meeting of the
Stewardship, USMA 2035, Culture of Ghostlaw, the committee Designated Uniform Formulary Beneficiary
Excellence, Highlights from Academic Federal Officer, via electronic mail, the Advisory Panel will take place.
Year 2018. preferred mode of submission, at the DATES: Open to the Public Thursday,
Public’s Accessibility to the Meeting: address listed in the FOR FURTHER July 12, 2018, from 9:00 a.m. to 12:00
Pursuant to 5 U.S.C. 552b and 41 CFR INFORMATION CONTACT section. Each page p.m.
102–3.140 through 102–3.165 and of the comment or statement must
subject to the availability of space, this include the author’s name, title or ADDRESSES: The address of the open
meeting is open to the public. Seating is affiliation, address, and daytime phone meeting is the Naval Heritage Center
on a first to arrive basis. Attendees are number. Written comments or Theater, 701 Pennsylvania Avenue NW,
requested to submit their name, statements should be submitted to Mrs. Washington, DC 20004.
affiliation, and daytime phone number Ghostlaw, the committee Designated FOR FURTHER INFORMATION CONTACT: Col
seven business days prior to the meeting Federal Officer, via electronic mail, the Paul J. Hoerner, U.S. Air Force, 703–
to Mrs. Ghostlaw, via electronic mail, preferred mode of submission, at the 681–2890 (Voice), None (Facsimile),
the preferred mode of submission, at the address listed in the FOR FURTHER dha.ncr.health-it.mbx.baprequests@
address listed in the FOR FURTHER INFORMATION CONTACT section. Written mail.mil (Email). Mailing address is
INFORMATION CONTACT section. Pursuant comments or statements being 7700 Arlington Boulevard, Suite 5101,
to 41 CFR 102–3.140d, the committee is submitted in response to the agenda set Falls Church, VA 22042–5101. Website:
not obligated to allow a member of the forth in this notice must be received by http://www.health.mil/About-MHS/
public to speak or otherwise address the the Designated Federal Official at least Other-MHS-Organizations/Beneficiary-
committee during the meeting, and seven business days prior to the meeting Advisory-Panel. The most up-to-date
members of the public attending the to be considered by the committee. The changes to the meeting agenda can be
committee meeting will not be Designated Federal Official will review found on the website.
permitted to present questions from the all timely submitted written comments SUPPLEMENTARY INFORMATION: This
floor or speak to any issue under or statements with the committee meeting is being held under the
consideration by the committee. Chairperson and ensure the comments provisions of the Federal Advisory
Because the committee meeting will be are provided to all members of the Committee Act (FACA) of 1972 (5
held in a Federal Government facility on committee before the meeting. Written U.S.C., Appendix, as amended), the
a military post, security screening is comments or statements received after Government in the Sunshine Act of
required. A government photo ID is this date may not be provided to the 1976 (5 U.S.C. 552b, as amended), and
required to enter post. In order to enter committee until its next meeting. 41 CFR 102–3.140 and 102–3.150.
the installation, members of the public Pursuant to 41 CFR 102–3.140d, the Purpose of Meeting: The Panel will
must first go to the Visitor Control committee is not obligated to allow a review and comment on
Center in the Visitor Center and go member of the public to speak or recommendations made to the Director
through a background check before otherwise address the committee during of the Defense Health Agency, by the
being allowed access to the installation. the meeting. However, the committee Pharmacy and Therapeutics Committee,
Members of the public then need to park Designated Federal Official and regarding the Uniform Formulary.
in Buffalo Soldier Field parking lot and Chairperson may choose to invite Purpose of the Meeting: The
ride the Central Post Area (CPA) shuttle certain submitters to present their Department of Defense is publishing
bus to the meeting location. Please note comments verbally during the open this notice to announce a Federal
that all vehicles and persons entering portion of this meeting or at a future Advisory Committee meeting of the
the installation are subject to search meeting. The Designated Federal Uniform Formulary Beneficiary
and/or an identification check. Any Officer, in consultation with the Advisory Panel (hereafter referred to as
person or vehicle refusing to be committee Chairperson, may allot a the Panel) will take place.
searched will be denied access to the
specific amount of time for submitters to
installation. Members of the public Agenda
present their comments verbally.
should allow at least an hour for 1. Sign-In
security checks and the shuttle ride. The Brenda S. Bowen,
2. Welcome and Opening Remarks
United States Military Academy, Army Federal Register Liaison Officer. 3. Scheduled Therapeutic Class Reviews
Jefferson Hall, is fully handicap [FR Doc. 2018–12501 Filed 6–8–18; 8:45 am] (Comments will follow each agenda
accessible. Wheelchair access is BILLING CODE 5001–03–P item)
available at the south entrance of the a. Gastrointestinal-2 Miscellaneous
building. For additional information Agents—Opioid-Induced
about public access procedures, contact DEPARTMENT OF DEFENSE Constipation Subclass
Mrs. Ghostlaw, the committee’s b. Growth Stimulating Agents
Designated Federal Officer, at the email Office of the Secretary
c. Pancreatic Enzyme Replacement
address or telephone number listed in
Uniform Formulary Beneficiary Therapy Agents
the FOR FURTHER INFORMATION CONTACT
Advisory Panel; Notice of Federal 4. Newly Approved Drugs Review
section.
daltland on DSKBBV9HB2PROD with NOTICES
Written Comments or Statements: Advisory Committee Meeting 5. Pertinent Utilization Management
Pursuant to 41 CFR 102–3.105(j) and Issues 6. Panel Discussions and
AGENCY: Under Secretary of Defense for Vote
102–3.140 and section 10(a)(3) of the Personnel and Readiness, Department of
Federal Advisory Committee Act, the Defense. Meeting Accessibility: Meeting
public or interested organizations may Accessibility: Pursuant to 5 U.S.C. 552b,
ACTION: Notice of Federal Advisory
submit written comments or statements as amended, and 41 Code of Federal
Committee meeting.
to the committee, in response to the Regulations (CFR) 102–3.140 through
VerDate Sep<11>2014 19:19 Jun 08, 2018 Jkt 244001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\11JNN1.SGM 11JNN1](https://thefederalregister.org/doc/83_FR_27104/page/1.svg)
![Federal Register / Vol. 83, No. 112 / Monday, June 11, 2018 / Notices 26993
102–3.165, and the availability of space, recommendations on matters related to represented by the Secretary of the
this meeting is open to the public. the mission, policy, accreditation, Navy, for domestic and foreign licensing
Seating is limited and will be provided faculty, students, facilities, curricula, by the Department of the Navy.
only to the first 220 people signing-in. educational methods, research, and ADDRESSES: Requests for copies of the
All persons must sign-in legibly. administration of the National patent applications cited should be
Written Statements: Written Intelligence University. directed to Naval Surface Warfare
Statements: Pursuant to 41 CFR 102– The Board is composed of no more Center, Crane Div., Code OOL, Bldg. 2,
3.140, the public or interested than 12 members who have extensive 300 Highway 361, Crane, IN 47522–
organizations may submit written professional experience in the fields of 5001.
statements to the membership of the national intelligence, national defense,
FOR FURTHER INFORMATION CONTACT: Mr.
Panel about its mission and/or the and academia. The following ex-officio
agenda to be addressed in this public Christopher Monsey, Naval Surface
positions shall also serve on the Board:
meeting. Written statements should be Warfare Center, Crane Div., Code OOL,
The Under Secretary for Intelligence
submitted to the Panel’s Designated Bldg. 2, 300 Highway 361, Crane, IN
and Analysis, U.S. Department of
Federal Officer (DFO).The DFO’s 47522–5001, Email
Homeland Security; the Assistant
contact information can be obtained Christopher.Monsey@navy.mil, 812–
Director of National Intelligence for
previously in this announcement. 854–2777.
Human Capital and Chief Human
Written comments or statements must Capital Officer for the Intelligence SUPPLEMENTARY INFORMATION: The
be received by the committee DFO at Community, DoD Office of the Director following patent application is available
least five (5) business days prior to the of National Intelligence, and; the Deputy for licensing: Patent Application No. 14/
meeting so that they may be made Executive Director of management and 953,315 (Navy Case No. 200226):
available to the Panel for its Learning, Central Intelligence Agency Optimized Subsonic Projectiles and
consideration prior to the meeting. The and Chief Learning Officer, Central Related Methods.
DFO will review all submitted written Intelligence Agency University. All Authority: 35 U.S.C. 207, 37 CFR part 404.
statements and provide copies to all the members of the Board are appointed to Dated: June 5, 2018.
committee members. provide advice on behalf of the E.K. Baldini,
Dated: June 6, 2018. Government on the basis of their best
Lieutenant Commander, Judge Advocate
Shelly E. Finke, judgment without representing any General’s Corps, U.S. Navy, Federal Register
Alternate OSD Federal Register Liaison
particular point of view and in a manner Liaison Officer.
Officer, Department of Defense. that is free from conflict of interest. [FR Doc. 2018–12522 Filed 6–8–18; 8:45 am]
[FR Doc. 2018–12445 Filed 6–8–18; 8:45 am]
Except for reimbursement of official
BILLING CODE 3810–FF–P
Board -related travel and per diem,
BILLING CODE 5001–06–P
Board members serve without
compensation.
The public or interested organizations DEPARTMENT OF ENERGY
DEPARTMENT OF DEFENSE
may submit written statements to the Federal Energy Regulatory
Office of the Secretary Board membership about the Board’s Commission
mission and functions. Written
Charter Renewal of Department of statements may be submitted at any Combined Notice of Filings #1
Defense Federal Advisory Committees time or in response to the stated agenda
of planned meeting of the Board. All Take notice that the Commission
AGENCY: Department of Defense. received the following electric rate
written statements shall be submitted to
ACTION: Renewal of Federal Advisory filings:
the DFO for the Board, and this
Committee. individual will ensure that the written Docket Numbers: ER10–1276–008;
SUMMARY: The Department of Defense statements are provided to the ER10–1287–007; ER10–1292–007;
(DoD) is publishing this notice to membership for their consideration. ER10–1303–007; ER10–1319–009;
announce that it is renewing the charter Dated: June 5, 2018.
ER10–1353–009.
for the National Intelligence University Applicants: Consumers Energy
Shelly E. Finke,
Board of Visitors (‘‘the Board’’). Company, CMS Energy Resource
Alternate OSD Federal Register Liaison Management Company, Grayling
FOR FURTHER INFORMATION CONTACT: Jim Officer, Department of Defense.
Generating Station Limited Partnership,
Freeman, Advisory Committee [FR Doc. 2018–12439 Filed 6–8–18; 8:45 am] Genesee Power Station Limited
Management Officer for the Department BILLING CODE 5001–06–P Partnership, CMS Generation Michigan
of Defense, 703–692–5952.
Power, LLC, Dearborn Industrial
SUPPLEMENTARY INFORMATION: The
Generation, L.L.C.
Board’s charter is being renewed in DEPARTMENT OF DEFENSE Description: Notice of Non-Material
accordance with the Federal Advisory Change-In-Status of Consumer Energy
Committee Act (FACA) of 1972 (5 Department of the Navy
Company, et. al.
U.S.C., Appendix, as amended) and 41 Filed Date: 5/31/18.
CFR 102–3.50(d). The Board’s charter Notice of Availability of Government-
Owned Inventions; Available for Accession Number: 20180531–5437.
and contact information for the Board’s Comments Due: 5 p.m. ET 6/21/18.
Designated Federal Officer (DFO) can be Licensing Docket Numbers: ER18–1731–000.
daltland on DSKBBV9HB2PROD with NOTICES
found at http://www.facadatabase.gov/. AGENCY: Department of the Navy, DoD. Applicants: Midcontinent
The Board provides the Secretary of ACTION: Notice. Independent System Operator, Inc.
Defense and the Deputy Secretary of Description: § 205(d) Rate Filing:
Defense, through the Under Secretary of SUMMARY: The Department of the Navy 2018–06–01_Filing of MISO TOs for
Defense for Intelligence (USD(I)) and the (DoN) announces the availability of the Cost Recovery of Operating and
Director, Defense Intelligence Agency, inventions listed below, assigned to the Maintenance Exp to be effective 8/1/
independent advice and United States Government, as 2018.
VerDate Sep<11>2014 19:19 Jun 08, 2018 Jkt 244001 PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 E:\FR\FM\11JNN1.SGM 11JNN1](https://thefederalregister.org/doc/83_FR_27104/page/2.svg)
Document Created: 2018-11-02 11:58:46
Document Modified: 2018-11-02 11:58:46
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of Federal Advisory Committee meeting. | |
| Dates | Open to the Public Thursday, July 12, 2018, from 9:00 a.m. to 12:00 p.m. | |
| Contact | Col Paul J. Hoerner, U.S. Air Force, 703-681-2890 (Voice), None (Facsimile), dha.ncr.health- | |
| FR Citation | 83 FR 26992 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR